Does VORETIGENE NEPARVOVEC Cause Injection site atrophy? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Injection site atrophy have been filed in association with VORETIGENE NEPARVOVEC. This represents 39.5% of all adverse event reports for VORETIGENE NEPARVOVEC.
15
Reports of Injection site atrophy with VORETIGENE NEPARVOVEC
39.5%
of all VORETIGENE NEPARVOVEC reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site atrophy From VORETIGENE NEPARVOVEC?
Of the 15 reports.
Is Injection site atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VORETIGENE NEPARVOVEC. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does VORETIGENE NEPARVOVEC Cause?
Retinal degeneration (25)
Intraocular pressure increased (8)
Metamorphopsia (6)
Migraine (6)
Pharyngitis (6)
Urticaria (6)
Chronic spontaneous urticaria (5)
Headache (5)
What Other Drugs Cause Injection site atrophy?
GLATIRAMER (282)
ASFOTASE ALFA (144)
TRIAMCINOLONE ACETONIDE (121)
INTERFERON BETA-1A (103)
INTERFERON BETA-1B (44)
TRIAMCINOLONE (34)
INSULIN GLARGINE-YFGN (27)
MEDROXYPROGESTERONE (22)
INSULIN GLARGINE (17)
SOMATROPIN (17)